MRL Ventures Fund
Cambridge, United States · Pre-seed → Series A
Their stated focus (public profile)
MRL Ventures Fund (MRLV) is a therapeutics-focused corporate venture group that invests globally in early-stage, preclinical therapeutics companies across all modalities—from small molecules to cell therapies. The fund backs first- and best-in-class therapeutic innovation with the goal of transforming standards of care, evaluating opportunities based on strength of underlying biology, translational data quality, and development path to human proof-of-concept. MRLV provides up to $25M per company alongside strategic guidance and access to MSD's R&D expertise, taking active board or observer roles. The fund focuses exclusively on therapeutics and does not invest in medical devices, diagnostic platforms, or digital health.
Stages: Pre-seed → Series A
Sectors: Life sciences
Check size: Up to $25M per company
On file: 23 companies on record
Website: mrlv.com
This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.
Is this your fund? Request a correction or removal.
Search the funds we have on file
Looking for investors? Search the funds we have on file — what they back, where they are, and whether your raise fits. Sign in and Percy matches you to the right ones.
Looking to claim your own fund? Start here →
This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.
Funds closest to this thesis
Ordered by how close each thesis sits to this one.
Is this your fund? Request a correction or removal.